Haemonetics (HAE) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $77.62 --0%
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.39
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +2.3%
Financial Fact:
Net income: 0.39
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.90, $0.01 better than the analyst estimate of $0.89. Revenue for the quarter came in at $343.29 million versus the consensus estimate of $329.47 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Rothschild Redburn Starts Mosaic (MOS) at Buy
- Oppfi (OPFI) Reiterated at Market Outperform by Citizens After Management Meet
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
